Retinal ganglion cell loss in neuromyelitis optica: a longitudinal studyFrederike Cosima Oertel, Alexander U. Brandt, Nadja Borisow et al.|Journal of Neurology Neurosurgery & Psychiatry|2018Cited by 115
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce Cree, Piotr Sokolowski, Gary Cutter et al.|The Lancet Neurology|2020Cited by 104
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal studyFrederike Cosima Oertel, AU Brandt, Joachim Havla et al.|MDC Repository (Max-Delbrueck-Center for Molecular Medicine)|2018Cited by 16